TheraRadar
Data updated: May 26, 2026

NORETHINDRONE

Women's Health Approved 2010-07-22

Norethindrone is a progestin-only oral contraceptive used to prevent pregnancy. This medication helps patients who are seeking a hormonal method of birth control to avoid unintended conception. It is often prescribed as an alternative to combined pills, though its effectiveness depends on the patient taking the medication consistently to avoid failure.

Source: FDA Label • XIROMED • Progestin

How NORETHINDRONE Works

This medication works by thickening the cervical mucus to inhibit sperm penetration and suppressing ovulation in approximately half of users. It also lowers midcycle hormone peaks, slows the movement of the egg through the fallopian tubes, and alters the uterine lining to prevent pregnancy.

Source: FDA Label
7
Indications
--
Phase 3 Trials
15
Years on Market

Details

Status
Prescription
First Approved
2010-07-22
Routes
ORAL-28
Dosage Forms
TABLET

NORETHINDRONE Approval History

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
19 FDA actions from 2010 to 2024
Mar 2024 SUPPL
Label · Labeling
May 2023 SUPPL
Label · Labeling
Sep 2022 SUPPL
Label · Labeling

What NORETHINDRONE Treats

1 indications

NORETHINDRONE is approved for 1 conditions since its original approval in 2010. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Pregnancy prevention
Source: FDA Label

NORETHINDRONE Competitive Set

Pro

Three rings of competition based on shared molecular targets and treated indications.

Unlock 8 more competitors across all three rings.
Upgrade to Pro

Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.

Drugs Similar to NORETHINDRONE

3 of 20

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

AMABELZ
ESTRADIOL
1 shared
Lupin
Shared indications:
Pregnancy prevention
ANNOVERA
ETHINYL ESTRADIOL
1 shared
MAYNE PHARMA
Shared indications:
Pregnancy prevention
ASHLYNA
ETHINYL ESTRADIOL
1 shared
GLENMARK PHARMS LTD
Shared indications:
Pregnancy prevention
📋

Clinical Trial Registry

2 trials
Trial Sponsor ID Phase Status Title
NCT03106454 HS-09-00669 Ph 3 completed Ovulation Incidence in Oral Contraceptive Users
NCT02652650 CR108093 63623872FLZ1009, 2015-000639-34 Ph 1 completed A Study to Investigate the Effect of JNJ-63623872 at Steady-state on the Steady-state Pharmacokinetics of Ethinylestradiol and Norethindrone
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

NORETHINDRONE FDA Label Details

Indications & Usage

NORETHINDRONE is indicated for the treatment of Pregnancy prevention.

Looking for the branded version?

ERRIN

Full clinical data, patents, trials, and competitive landscape for norethindrone.

See ERRIN

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.